| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001754154-26-000010.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001754154-26-000010.txt","company":"Whitehawk Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001754154-26-000010.txt","article_chars":2218,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_246969c4173dbde6","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001754154-26-000010.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:14:51.446834+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001754154-26-000010.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001754154-26-000010.txt","source_event_id":"evt_0fd502add3d1","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"2248d23c7ad6b5b7","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-15","2026-04-16","2026-04-15","2022-11-14","2025-11-15","2021-08-26","2017-03-16","2007-12-27"],"entities":[{"asset_class":"equity","name":"Whitehawk Therapeutics, Inc.","relevance":"high","symbol":"WHWK","type":"issuer"},{"asset_class":"person","name":"Scott M. Giacobello","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"plan","name":"2021 Employee Stock Purchase Plan","relevance":"medium","symbol":"","type":"equity_plan"}],"event_type":"other","information_gaps":["The cleaned text does not explicitly state whether the reported transactions are sales only or include purchases beyond the broker-assisted sale description.","The cleaned text does not provide the exact number of shares tied to the restricted stock unit vesting beyond the aggregate 11,822 shares acquired under the 2021 Employee Stock Purchase Plan.","No prior known state (e.g., earlier Form 4s or previous holdings) is included in the provided input, so the 'what changed vs prior known state' cannot be determined from this signal alone."],"key_facts":["SEC filing type: Form 4 (conformed submission type: 4).","Issuer: Whitehawk Therapeutics, Inc. (ticker shown: WHWK).","Reporting person: Scott M. Giacobello M. (listed as reporting-owner).","Filing accession number: 0001754154-26-000010.","Conformed period of report: 2026-04-15; filed as of date: 2026-04-17.","The filing includes Common Stock transactions with the following disclosed share counts and prices: 77,000 shares at $3.86 and 141,600 shares at $4.13 (as shown in the cleaned text).","The filing states the transactions represent a broker-assisted sale to satisfy the reporting person\u2019s tax withholding obligations in connection with the vesting of restricted stock units.","The filing states the broker-assisted sale includes an aggregate of 11,822 shares acquired between November 14, 2022 and November 15, 2025 under the Issuer\u2019s 2021 Employee Stock Purchase Plan."],"numeric_claims":[{"label":"Shares sold (first line)","value":"77000"},{"label":"Price per share (first line)","value":"3.86"},{"label":"Shares sold (second line)","value":"141600"},{"label":"Price per share (second line)","value":"4.13"},{"label":"Aggregate shares acquired under 2021 Employee Stock Purchase Plan","value":"11822"}],"primary_claim":"On 2026-04-17, Whitehawk Therapeutics, Inc. filed Form 4 reporting a broker-assisted sale of Common Stock by Scott M. Giacobello to satisfy tax withholding obligations tied to vested restricted stock units.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Whitehawk Therapeutics, Inc. (WHWK) filed a Form 4 on 2026-04-17 reporting transactions by reporting person Scott M. Giacobello. The filing indicates a broker-assisted sale of shares to cover tax withholding related to vested restricted stock units.","topics":["SEC Form 4","insider transaction","restricted stock units","tax withholding","broker-assisted sale","employee stock purchase plan"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Whitehawk Therapeutics, Inc. \u00b7 Filed 20260417","ticker":"WHWK","tickers":["WHWK"],"title":"WHWK filed 4","url":"https://www.sec.gov/Archives/edgar/data/1422142/0001754154-26-000010.txt"}... |